Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.

"The authors would like to remember Stavros Tourkodimitris, who passed away on 18 December 2019, after this manuscript was submitted. The authors would like to thank Harvey Schneier for his advice and contributions throughout the manuscript development. Declaration of personal interests: Michael Camilleri and Anthony Lembo have served as advisory board members and are grant recipients of Rhythm Pharmaceuticals. Michael Camilleri is currently conducting research funded by Allergan plc. Richard McCallum is a consultant for and grant recipient of Rhythm Pharmaceuticals. Lara Kemps, Matthew B. Miller, Kirk Bertelsen and Alexandru Iacob are employees of and own stock or stock options in Allergan plc. Stavros Tourkodimitris (deceased) was an employee of Allergan plc and owned stock or stock options in Allergan plc."

"Funding information"